Senior Vice President, Research & Development
Prior to joining Polaris in 2008, James Thomson spent 15 years as a biophysicist at Agouron Pharmaceuticals, Warner-Lambert and Pfizer. He established and directed the Biophysics Group in the Biochemical Pharmacology Department. He was involved in the development of research tools, such as algorithms for the de novo design of small-molecule lead compounds, and used his expertise in protein biochemistry to develop biologics intended for the treatment of cancer and other diseases. Dr. Thomson has held the position of chair of the Molecular Interactions Research Group of the Association of Biomolecular Resource Facilities. He received a Ph.D. in Biochemistry from Texas A&M University and postdoctoral training at Yale University.